Document is current
Any future updates will be listed below
-
Authors
Zhao, Lan
Ni, Beibei
Li, Jinqing
Liu, Rui
Zhang, Qi
Zheng, Zhuangbin
Yang, Wenjuan
Yu, Wei
Bi, Lijun https://orcid.org/0009-0002-4859-3178
-
Funding
Funding for this research was provided by:
Science Assistance Project for Xinjiang (2024E02062)
National Natural Science Foundation of China (3239014, 82304575)
Guangdong Provincial Basic and Applied Basic Research Fund (2022A1515110883)
Young Scientists Program of Guangzhou Laboratory (No. QNPG24-09)
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 18 September 2024
First Online: 27 September 2024
Declarations
:
: This study has been approved by the Ethics Committee of The Third Affiliated Hospital of Sun Yat-sen University. Informed consent was obtained from healthy donors prior to the collection of UCs. The research project titled “Multi-center randomized controlled clinical study of allogeneic human umbilical cord mesenchymal stem cells in the treatment of hepatitis B related chronic and acute liver dysfunction” was approved on December 30, 2020 (approval number: 202014).
: Not applicable.
: The authors declare that they have no competing interests.
